Abstract
1. The β-adrenoceptor antagonist activity of 3-methoxyisoprenaline, the O-methylated metabolite of isoprenaline, was studied on isolated driven atrial strip and tracheal chain preparations of the guinea-pig and on the hind limb blood flow of the dog.
2. On both the atrial strip and tracheal chain preparations the blockade of responses to isoprenaline fulfilled the criteria for simple competitive inhibition.
3. 3-Methoxyisoprenaline decreased the vasodilator response to isoprenaline in the dog hind limb, but did not affect the response to noradrenaline.
4. 3-Methoxyisoprenaline had about 1/3,700 of the potency of propranolol as a β-adrenoceptor antagonist on the tracheal chain preparation, 1/1,000 on the atrial strip preparation and less than 1/400 on the hind limb blood flow.
5. The antagonist activity of 3-methoxyisoprenaline showed a slight specificity for cardiac β-adrenoceptors, being 4·3 times more active on guinea-pig atria than on trachea.
6. Although 3-methoxyisoprenaline antagonized the actions of isoprenaline in the three preparations, its activity was extremely weak. It is unlikely that the formation of 3-methoxyisoprenaline from isoprenaline, administered therapeutically, could lead to β-adrenoceptor blockade.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blinks J. R. Evaluation of the cardiac effects of several beta adrenergic blocking agents. Ann N Y Acad Sci. 1967 Feb 10;139(3):673–685. doi: 10.1111/j.1749-6632.1967.tb41237.x. [DOI] [PubMed] [Google Scholar]
- Blinks J. R. Field stimulation as a means of effecting the graded release of autonomic transmitters in isolated heart muscle. J Pharmacol Exp Ther. 1966 Feb;151(2):221–235. [PubMed] [Google Scholar]
- Conway W. D., Minatoya H., Lands A. M., Shekosky J. M. Absorption and elimination profile of isoproterenol. 3. The metabolic fate of dl-isoproterenol-7-3H in the dog. J Pharm Sci. 1968 Jul;57(7):1135–1141. doi: 10.1002/jps.2600570710. [DOI] [PubMed] [Google Scholar]
- Farmer J. B., Levy G. P. Differentiation of beta-adrenoreceptors by the use of blocking agents. J Pharm Pharmacol. 1970 Feb;22(2):145–146. doi: 10.1111/j.2042-7158.1970.tb08414.x. [DOI] [PubMed] [Google Scholar]
- Foster R. W. The nature of the adrenergic receptors of the trachea of the guinea-pig. J Pharm Pharmacol. 1966 Jan;18(1):1–12. doi: 10.1111/j.2042-7158.1966.tb07764.x. [DOI] [PubMed] [Google Scholar]
- HERTTING G. THE FATE OF 3H-ISO-PROTERENOL IN THE RAT. Biochem Pharmacol. 1964 Aug;13:1119–1128. doi: 10.1016/0006-2952(64)90112-1. [DOI] [PubMed] [Google Scholar]
- LANDS A. M., BROWN T. G., Jr A COMPARISON OF THE CARDIAC STIMULATING AND BRONCHODILATOR ACTIONS OF SELECTED SYMPATHOMIMETIC AMINES. Proc Soc Exp Biol Med. 1964 Jun;116:331–333. doi: 10.3181/00379727-116-29239. [DOI] [PubMed] [Google Scholar]
- McNeill R. S., Ingram C. G. Effect of propranolol on ventilatory function. Am J Cardiol. 1966 Sep;18(3):473–475. doi: 10.1016/0002-9149(66)90072-5. [DOI] [PubMed] [Google Scholar]
- Paterson J. W., Conolly M. E., Davies D. S., Dollery C. T. Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet. 1968 Aug 24;2(7565):426–429. doi: 10.1016/s0140-6736(68)90467-4. [DOI] [PubMed] [Google Scholar]
- SCHILD H. O. Drug antagonism and pAx. Pharmacol Rev. 1957 Jun;9(2):242–246. [PubMed] [Google Scholar]